CC stock news · Chemours
Get alerts for CC
Follow Chemours (CC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CCFree on the App Store and Google Play, or on the web.
Chemours shares the full details from its earnings call for the second quarter of 2026.
NeutralChemours' sales came in slightly below expectations, but adjusted EBITDA beat them on stronger operations and pricing. Softer demand and an expected Q3 sales decline balance debt reduction and specialty-product growth.
Chemours Co has signed a big agreement to settle with DuPont and Corteva for $455 million.
Bad for CCChemours agreed to a $455M settlement and will pay about half over 15 years; this increases its legal and cleanup obligations while easing immediate cash needs.
Chemours Co shared a report about a presentation for future meetings with investors.
NeutralChemours posted a Regulation FD investor presentation on Sept 9, 2026. The 8-K furnishes slides and contains no new sales or profit numbers, so the filing leaves Chemours' outlook unchanged.